Long-term clinical course and outcomes in patients with lymphangioleiomyomatosis

BACKGROUND: Lymphangioleiomyomatosis (LAM) is a rare multisystemic disorder with various clinical manifestations. Despite the recognition of several prognostic factors, the long-term clinical course and prognosis of patients with LAM in the era of sirolimus therapy are not established. METHODS: The...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Hee-Young, Kim, Ho Jeong, Song, Jin Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206248/
https://www.ncbi.nlm.nih.gov/pubmed/35717210
http://dx.doi.org/10.1186/s12931-022-02079-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206248/
https://www.ncbi.nlm.nih.gov/pubmed/35717210
http://dx.doi.org/10.1186/s12931-022-02079-6

Ejemplares similares